LANGENFELD, Germany, May 28, 2019 /PRNewswire/ -- Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announces it will soon launch its first probiotic[1] in the European market following an exclusive...
from PR Newswire: https://prn.to/2YQtaV8
No comments:
Post a Comment